SCHEMBL27634211

SCHEMBL27634211

O=[N+]([O-])c1ccc2c(c1)C(Br)CN2

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNB4 P30926 4/20 0.49
CHRNA3 P32297 4/20 0.49
CAPN9 O14815 1/20 0.44
CASP3 P42574 1/20 0.44
CHRNB2 P17787 2/20 0.43
CHRNA4 P43681 2/20 0.43
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
HSP90AA1 P07900 1/20 0.41
GAPDH P04406 1/20 0.40
HSPA1A P0DMV8 1/20 0.40
HSPA8 P11142 1/20 0.40
CD44 P16070 1/20 0.40
MSN P26038 1/20 0.40
PTPN7 P35236 1/20 0.40
EZH2 Q15910 1/20 0.40
CYP3A4 P08684 2/20 0.40
TDP1 Q9NUW8 2/20 0.40
SNCA P37840 1/20 0.40
USP7 Q93009 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27492634 0.87 CHRNB4 (0.49) CHRNB4CHRNA3CAPN9CASP3CHRNB2
SCHEMBL9942558 0.81 CHRNB4 (0.49) CHRNB4CHRNA3CAPN9CASP3CHRNB2
SCHEMBL27596768 0.81 CHRNB4 (0.49) CHRNB4CHRNA3CAPN9CASP3CHRNB2
SCHEMBL12813209 0.81 CHRNB4 (0.49) CHRNB4CHRNA3CAPN9CASP3CHRNB2
SCHEMBL28799453 0.78 CHRNB4 (0.47) CHRNB4CHRNA3CAPN9CASP3CHRNB2
SCHEMBL13362026 0.77 CHRNB4 (0.46) CHRNB4CHRNA3CHRNB2CHRNA4HSP90AA1
SCHEMBL8113614 0.77 GAPDH (0.52) CHRNB4CHRNA3CHRNB2CHRNA4HSP90AA1
SCHEMBL27654661 0.77 NPSR1 (0.46) CHRNB4CHRNA3CAPN9CASP3CHRNB2
SCHEMBL27910587 0.77 CHRNB4 (0.46) CHRNB4CHRNA3CHRNB2CHRNA4HSP90AA1
SCHEMBL27821121 0.77 CHRNB4 (0.46) CHRNB4CHRNA3CHRNB2CHRNA4HSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104073045-B Halogeno indole and derivant thereof are as the application of marine antifoulant 中国科学院烟台海岸带研究所 2016-12-28 CN disclosed
CN-101605758-A Methods of treating hepatitis C PTC THERAPEUTICS INC (US) 2009-12-16 CN disclosed
CN-101541748-A Methods for treating hepatitis C PTC THERAPEUTICS INC (US) 2009-09-23 CN disclosed
CN-101027051-A Methods for treating hepatitis C PTC THERAPEUTICS INC (US) 2007-08-29 CN disclosed
CN-1764651-A Quinazoline derivatives as antitumor agents ASTRAZENECA AB (SE) 2006-04-26 CN disclosed